Evidence map›Paper›PMID 32983953›Full record

ArticleJournal of epilepsy research2020

Epilepsy Research in Mali: A Pilot Pharmacokinetics Study on First-Line Antiepileptic Drug Treatment.

Modibo Sangare, Fatoumata Doumbia, Oumar Sidibe, Aboucacar Alassane Oumar, Sekou Bah, Modibo Kouyate, Seidina S Diakite, Karim Traore, Adama Karembe, Mohamed S Haidara and 12 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of epilepsy research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 4 countries.

Modibo SangareFaculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar.
Fatoumata DoumbiaFaculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar.
Oumar SidibeFaculty of Pharmacy, University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, State of Qatar.
Aboucacar Alassane OumarFaculty of Pharmacy, University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, State of Qatar.
Sekou BahFaculty of Pharmacy, University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, State of Qatar.
Modibo KouyateAfrican Center of Excellence in Bio-informatics (ACE), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamakom, State of Qatar.
Seidina S DiakiteFaculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar.
Karim TraoreFaculty of Pharmacy, University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, State of Qatar.
Adama KarembeFaculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar.
Mohamed S HaidaraFaculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar.
Souleymane P CoulibalyFaculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar.
Souleymane CoulibalyFaculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar.
Arouna TogoraFaculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar.
Housseini DoloFaculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar.
Drissa TraoreFaculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar.
Seydou DoumbiaFaculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar.
Mahamadou DiakiteFaculty of Pharmacy, University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, State of Qatar.
Youssoufa MaigaFaculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar.
Amadou DiawaraAlgi Biomedical Analysis Lab, Bamako, Mali, State of Qatar.
Callixte KuateCentral Neurology Hospital, Yaounde, Cameroun, State of Qatar.
Hyung-Goo KimNeurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Doha, State of Qatar.
Gordon A AwandareWest African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra, Ghana, State of Qatar.
Université des Sciences, des Techniques et des Technologies de Bamako · MLUniversity of Ghana · GHCentral Hospital of Yaoundé · CMQatar Cardiovascular Research Center · QA

Funding

West African Center of Excellence for Global Health Bioinformatics Research TrainingU2RTW010673 · FIC · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI DOUMBIA, SEYDOU, LI, JIAN · 2017 to 2021
$1.2M
FIC NIH HHS U2R TW010673Wellcome Trust
6 · The paper itself

Abstract

background and purposeThe indication and benefit of plasma level of antiepileptic (AEDs) has been debating in the monitoring of people living with epilepsy and the epilepsy treatment gap has largely been documented in developed countries. This study was aimed to highlight the epilepsy treatment gap between rural and urban Mali.

methodsWe conducted a pilot study on AEDs treatment from September 2016 to May 2019. For 6 months, 120 children and young adults living with epilepsy (rural site, 90; urban site, 30) received phenobarbital, valproic acid and/or carbamazepine. At our rural study site, we determined the AED plasma levels, monitored the frequency, severity and the duration of seizure, and administered monthly the McGill quality of life questionnaire. At our urban study site, each patient underwent an electroencephalogram and brain computed tomography scan without close monitoring.

resultsAt the rural study site, patients were mostly on monotherapy; AED levels at 1 month (M1) (n=90) and at 3 months (M3) (n=27) after inclusion were normal in 50% at M1 versus 55.6% at M3, low in 42.2% at M1 versus 33.3% at M3 and high in 7.8% at M1 versus 11.1% at M3. AED levels at M1 and at M3 were significantly different

conclusionsEpilepsy diagnostic and treatment are a real concern in Mali. Our data showed appropriate AED treatment with close follow up resulted in a better quality of life of patients in rural Mali. We will promote the approach of personalized medicine in AED treatment in Mali.

Indexed as

CarbamazepineEpilepsyMaliPhenobarbitalQuality of lifeValproic acid

Identifiers

PMID32983953
PMCPMC7494886
OpenAlexW3084188177

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.